Details Of Alternative Splicing Circuitry That Promotes Cancer's Warburg Effect Revealed By Study
11/04/2011
Cancer cells maintain their life-style of extremely rapid growth and proliferation thanks to an enzyme called PK-M2 (pyruvate kinase M2) that alters the cells' ability to metabolize glucose - a phenomenon known as the Warburg effect. Professor Adrian Krainer, Ph.D...
Effectiveness And Safety Of New Treatment For Hemophilia Confirmed By Tulane-Led Study
11/04/2011
An international research team led by Dr. Cindy Leissinger of Tulane University School of Medicine, along with Dr. Alessandro Gringeri from the University of Milan, has found that a drug commonly used to treat bleeding events in people with a type of severe hemophilia can also be used to prevent such events from happening in the first place...
Albert Einstein College Of Medicine Receives $8 Million From NIH To Study How Cancer Spreads
11/04/2011
The National Cancer Institute (NCI) has awarded Albert Einstein College of Medicine of Yeshiva University two grants totaling $8 million to study the microenvironments that drive the spread of cancer from the primary tumor to other parts of the body in the process known as metastasis...
Vaccine Could Prevent Mononucleosis And Cancers Linked To Epstein-Barr Virus
11/04/2011
Epstein-Barr virus (EBV) infects nine out of ten people worldwide at some point during their lifetimes. Infections in early childhood often cause no disease symptoms, but people infected during adolescence or young adulthood may develop infectious mononucleosis, a disease characterized by swollen lymph nodes, fever and severe fatigue...
Depression And Breast Cancer Outcomes Linked
11/04/2011
This year, more than 230,000 women will be diagnosed with breast cancer and nearly 40,000 women will not survive their battle with cancer, according to the American Cancer Society. New research from the University of Missouri shows that certain factors, including marital status, having children in the home, income level and age, affect the likelihood of depression in breast cancer survivors...
Experimental Drug Shows Great Results On Prostate Cancer
11/04/2011
An experimental drug known as MDV3100 made by Medivation Inc. has improved survival rates for men with metastatic castration-resistant prostate cancer. Those on MDV3100 by Medivation outlived those on a placebo by an average of 4.8 months, in a phase 3 trial. The manufacturer Medivation Inc...
Use Of New Catalyst To Synthesize Two Potent Anti-Cancer Molecules
11/04/2011
Research carried out at Boston College, in collaboration with scientists at MIT and the University of Oxford, has led to the development of an efficient and highly selective catalyst for ring-closing olefin metathesis, one of the most widely used reactions in chemical synthesis, the team reports in this week's issue of the journal Nature...
Tactic To Delay Age-Related Disorders Discovered By Mayo Researchers
11/04/2011
Researchers at Mayo Clinic (http://www.mayoclinic.org) have shown that eliminating cells that accumulate with age could prevent or delay the onset of age-related disorders and disabilities. The study, performed in mouse models, provides the first evidence that these "deadbeat" cells could contribute to aging and suggests a way to help people stay healthier as they age...
Mayo Clinic researchers have discovered why measles, perhaps the most contagious viral disease in the world, spreads so quickly. The virus emerges in the trachea of its host, provoking a cough that fills the air with particles ready to infect the next host. The findings may also help in the fight against ovarian, breast and lung cancers...
Potential Treatment For Sickle Cell Disease
11/04/2011
A University of Michigan Health System laboratory study reveals a key trigger for producing normal red blood cells that could lead to a new treatment for those with sickle cell disease...